Abstract
In a nonrandomized feasibility study of therapeutic hypothermia in acute myocardial infarction, 18 patients were treated with endovascular cooling (Alsius, Irvine, California) as adjunctive therapy to primary percutaneous coronary intervention to assess measures of infarct size (area under the curve creatinine kinase-MB and technetium-99m single-photon emission computed tomography sestamibi) and the quality of myocardial perfusion (continuous ST-segment monitoring). Periprocedural endovascular cooling successfully decreased core body temperature (median 33.5 degrees C) and was well tolerated, which supports the evaluation of adjunctive hypothermia in pivotal trials to limit infarct size and decrease reperfusion injury.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angioplasty, Balloon, Coronary / adverse effects
-
Angioplasty, Balloon, Coronary / methods*
-
Combined Modality Therapy
-
Creatine Kinase / metabolism
-
Creatine Kinase, MB Form
-
Feasibility Studies
-
Female
-
Humans
-
Hypothermia, Induced / adverse effects
-
Hypothermia, Induced / methods*
-
Isoenzymes / metabolism
-
Male
-
Middle Aged
-
Myocardial Infarction / diagnostic imaging
-
Myocardial Infarction / metabolism
-
Myocardial Infarction / therapy*
-
Myocardial Reperfusion Injury / diagnostic imaging
-
Myocardial Reperfusion Injury / metabolism
-
Myocardial Reperfusion Injury / prevention & control*
-
Pilot Projects
-
Tomography, Emission-Computed, Single-Photon
-
Treatment Outcome
Substances
-
Isoenzymes
-
Creatine Kinase
-
Creatine Kinase, MB Form